Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs
Journal of Clinical Periodontology · 2026-01 · 53 (1) · 117-126
DOI: 10.1111/jcpe.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 16.09.2025. Verfasst von Wuda Huoshen und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Periodontitis, Pharmacovigilance. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Periodontitis is a common chronic inflammatory disease. However, drug‐related risks and underlying molecular mechanisms remain underexplored from large real‐world data.
Methods
We first mined the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to identify drugs disproportionately associated with periodontitis, using four signal detection algorithms and logistic regression for confounder adjustment. Identified drugs were then mapped to their protein targets via DrugBank, followed by pathway enrichment and protein–protein interaction (PPI) network analysis to explore biological relevance. To assess potential causality, we conducted Mendelian randomisation (MR) using cis‐pQTLs from UKB‐PPP and deCODE cohorts. Finally, we used single‐cell RNA sequencing (scRNA‐seq) data from gingival tissue and peripheral blood of periodontitis patients to evaluate cell type–specific expression of candidate causal genes.
Results
Five drugs (actonel, aclasta, aredia, amlodipine and avastin) were significantly positively associated with periodontitis based on FAERS. VEGFA showed an association with disease risk (OR = 1.043, p = 0.049) after meta‐analysis of two cohorts. scRNA‐seq data identified high VEGFA expression in monocytes in both gingival and blood samples of periodontitis patients.
Conclusion
This study uncovered the association between drug and periodontitis and highlighted VEGFA as a potential molecular mediator. Further studies are needed to confirm causality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Southwest Medical University, Luzhou, Sichuan, China.
- School of Stomatology, Nanchang University, Nanchang, Jiangxi, China.
- School of Health Caring Industry, Sichuan University of Arts and Science, Dazhou, Sichuan, China.
- Department of Endodontics, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Periodontics and Oral Mucosal Diseases, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China.
- Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatology Hospital, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Wuda Huoshen, Heng Wang
Zitieren
APA
Huoshen, W., Xiong, J., Ma, X., Wang, H., Cheng, P., Chen, X., Shuai, G., Chen, Y., Zhang, X., Sun, C., Li, C., & Shi, R. (2026). Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs. Journal of Clinical Periodontology, 53(1), 117-126. https://doi.org/10.1111/jcpe.70040
Vancouver
Huoshen W, Xiong J, Ma X, Wang H, Cheng P, Chen X, et al. Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs. Journal of Clinical Periodontology. 2026;53(1):117-126. doi:10.1111/jcpe.70040
BibTeX
@article{Huoshen2026,
author = {Huoshen, Wuda and Xiong, Junkai and Ma, Xunmi and Wang, Heng and Cheng, Panyu and Chen, Xinyu and Shuai, Ge and Chen, Yi and Zhang, Xinyue and Sun, Chen and Li, Chunhui and Shi, Rui},
title = {Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs},
journal = {Journal of Clinical Periodontology},
year = {2026},
volume = {53},
number = {1},
pages = {117--126},
doi = {10.1111/jcpe.70040}
}
EUVIMED